At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9 enrolled
Drug / intervention
continuous glucose monitoringdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings
University Hospitals Cleveland Medical Center·interventional·Posted Apr 25, 2022·Updated Feb 10, 2023
In Brief
A clinical study evaluating continuous glucose monitoring for Covid19 and Diabetes Mellitus. Completed, enrolled 9 participants across 1 site.
Detailed Summary
The objective of the study is to improve glycemic control in inpatient/ICU settings using real- time continuous glucose monitors (CGM) data for insulin titration. It may help reduce Coronavirus disease 2019 patient contact with healthcare workers as well.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19, Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJun 2020
Primary CompletionDec 2021
First PostedApr 2022
TodayJul 2026
First PostedApr 25, 2022
Enrollment StartJun 18, 2020
Primary CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.2 years ago
Interventions
continuous glucose monitoringdevice
Use of continuous glucose monitoring in inpatient and ICU settings